![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CEBPG |
Gene summary for CEBPG |
![]() |
Gene information | Species | Human | Gene symbol | CEBPG | Gene ID | 1054 |
Gene name | CCAAT enhancer binding protein gamma | |
Gene Alias | GPE1BP | |
Cytomap | 19q13.11 | |
Gene Type | protein-coding | GO ID | GO:0001775 | UniProtAcc | P53567 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1054 | CEBPG | P12T-E | Human | Esophagus | ESCC | 1.72e-36 | 9.49e-01 | 0.1122 |
1054 | CEBPG | P15T-E | Human | Esophagus | ESCC | 7.15e-42 | 9.15e-01 | 0.1149 |
1054 | CEBPG | P16T-E | Human | Esophagus | ESCC | 9.51e-17 | 2.09e-01 | 0.1153 |
1054 | CEBPG | P17T-E | Human | Esophagus | ESCC | 1.02e-14 | 6.09e-01 | 0.1278 |
1054 | CEBPG | P19T-E | Human | Esophagus | ESCC | 1.39e-05 | 9.52e-01 | 0.1662 |
1054 | CEBPG | P20T-E | Human | Esophagus | ESCC | 5.71e-23 | 6.52e-01 | 0.1124 |
1054 | CEBPG | P21T-E | Human | Esophagus | ESCC | 2.26e-21 | 3.67e-01 | 0.1617 |
1054 | CEBPG | P22T-E | Human | Esophagus | ESCC | 6.55e-28 | 6.30e-01 | 0.1236 |
1054 | CEBPG | P23T-E | Human | Esophagus | ESCC | 7.65e-41 | 1.19e+00 | 0.108 |
1054 | CEBPG | P24T-E | Human | Esophagus | ESCC | 3.45e-18 | 5.64e-01 | 0.1287 |
1054 | CEBPG | P26T-E | Human | Esophagus | ESCC | 2.44e-49 | 1.03e+00 | 0.1276 |
1054 | CEBPG | P27T-E | Human | Esophagus | ESCC | 8.56e-24 | 4.63e-01 | 0.1055 |
1054 | CEBPG | P28T-E | Human | Esophagus | ESCC | 5.61e-38 | 9.11e-01 | 0.1149 |
1054 | CEBPG | P30T-E | Human | Esophagus | ESCC | 1.81e-35 | 1.41e+00 | 0.137 |
1054 | CEBPG | P31T-E | Human | Esophagus | ESCC | 1.06e-42 | 9.27e-01 | 0.1251 |
1054 | CEBPG | P32T-E | Human | Esophagus | ESCC | 8.32e-33 | 9.77e-01 | 0.1666 |
1054 | CEBPG | P36T-E | Human | Esophagus | ESCC | 6.56e-16 | 6.18e-01 | 0.1187 |
1054 | CEBPG | P37T-E | Human | Esophagus | ESCC | 2.36e-16 | 3.69e-01 | 0.1371 |
1054 | CEBPG | P38T-E | Human | Esophagus | ESCC | 1.20e-18 | 1.18e+00 | 0.127 |
1054 | CEBPG | P39T-E | Human | Esophagus | ESCC | 1.20e-14 | 3.89e-01 | 0.0894 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0048732 | Colorectum | AD | gland development | 149/3918 | 436/18723 | 6.07e-11 | 6.33e-09 | 149 |
GO:0051098 | Colorectum | AD | regulation of binding | 126/3918 | 363/18723 | 6.01e-10 | 4.88e-08 | 126 |
GO:0051099 | Colorectum | AD | positive regulation of binding | 66/3918 | 173/18723 | 1.47e-07 | 6.64e-06 | 66 |
GO:0051052 | Colorectum | AD | regulation of DNA metabolic process | 116/3918 | 359/18723 | 2.47e-07 | 1.00e-05 | 116 |
GO:0051054 | Colorectum | AD | positive regulation of DNA metabolic process | 73/3918 | 201/18723 | 3.27e-07 | 1.29e-05 | 73 |
GO:0034101 | Colorectum | AD | erythrocyte homeostasis | 51/3918 | 129/18723 | 1.07e-06 | 3.59e-05 | 51 |
GO:0030099 | Colorectum | AD | myeloid cell differentiation | 119/3918 | 381/18723 | 1.24e-06 | 4.01e-05 | 119 |
GO:0002262 | Colorectum | AD | myeloid cell homeostasis | 57/3918 | 157/18723 | 6.17e-06 | 1.56e-04 | 57 |
GO:0061008 | Colorectum | AD | hepaticobiliary system development | 55/3918 | 150/18723 | 6.34e-06 | 1.59e-04 | 55 |
GO:0001889 | Colorectum | AD | liver development | 54/3918 | 147/18723 | 7.20e-06 | 1.77e-04 | 54 |
GO:0048872 | Colorectum | AD | homeostasis of number of cells | 87/3918 | 272/18723 | 1.16e-05 | 2.61e-04 | 87 |
GO:0030218 | Colorectum | AD | erythrocyte differentiation | 45/3918 | 120/18723 | 2.22e-05 | 4.39e-04 | 45 |
GO:2001020 | Colorectum | AD | regulation of response to DNA damage stimulus | 71/3918 | 219/18723 | 4.38e-05 | 7.65e-04 | 71 |
GO:0051101 | Colorectum | AD | regulation of DNA binding | 42/3918 | 118/18723 | 1.62e-04 | 2.23e-03 | 42 |
GO:0043388 | Colorectum | AD | positive regulation of DNA binding | 23/3918 | 56/18723 | 4.91e-04 | 5.32e-03 | 23 |
GO:2001022 | Colorectum | AD | positive regulation of response to DNA damage stimulus | 36/3918 | 105/18723 | 1.02e-03 | 9.47e-03 | 36 |
GO:0006282 | Colorectum | AD | regulation of DNA repair | 42/3918 | 130/18723 | 1.57e-03 | 1.32e-02 | 42 |
GO:0051091 | Colorectum | AD | positive regulation of DNA-binding transcription factor activity | 73/3918 | 260/18723 | 3.52e-03 | 2.54e-02 | 73 |
GO:00487322 | Colorectum | MSS | gland development | 143/3467 | 436/18723 | 3.85e-13 | 8.01e-11 | 143 |
GO:00510982 | Colorectum | MSS | regulation of binding | 113/3467 | 363/18723 | 3.55e-09 | 2.41e-07 | 113 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa051527 | Esophagus | ESCC | Tuberculosis | 111/4205 | 180/8465 | 7.14e-04 | 2.32e-03 | 1.19e-03 | 111 |
hsa0515212 | Esophagus | ESCC | Tuberculosis | 111/4205 | 180/8465 | 7.14e-04 | 2.32e-03 | 1.19e-03 | 111 |
hsa051526 | Oral cavity | OSCC | Tuberculosis | 105/3704 | 180/8465 | 5.00e-05 | 2.04e-04 | 1.04e-04 | 105 |
hsa0515211 | Oral cavity | OSCC | Tuberculosis | 105/3704 | 180/8465 | 5.00e-05 | 2.04e-04 | 1.04e-04 | 105 |
hsa0515221 | Oral cavity | LP | Tuberculosis | 65/2418 | 180/8465 | 1.60e-02 | 4.92e-02 | 3.17e-02 | 65 |
hsa0515231 | Oral cavity | LP | Tuberculosis | 65/2418 | 180/8465 | 1.60e-02 | 4.92e-02 | 3.17e-02 | 65 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CEBPG | SNV | Missense_Mutation | novel | c.258N>C | p.Lys86Asn | p.K86N | P53567 | protein_coding | deleterious(0) | benign(0.066) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CEBPG | SNV | Missense_Mutation | c.337N>G | p.Lys113Glu | p.K113E | P53567 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-EI-6882-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
CEBPG | SNV | Missense_Mutation | novel | c.64C>A | p.Gln22Lys | p.Q22K | P53567 | protein_coding | deleterious(0) | benign(0) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
CEBPG | SNV | Missense_Mutation | c.374N>G | p.His125Arg | p.H125R | P53567 | protein_coding | deleterious(0) | possibly_damaging(0.723) | TCGA-A5-A0GW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
CEBPG | SNV | Missense_Mutation | novel | c.339N>T | p.Lys113Asn | p.K113N | P53567 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CEBPG | SNV | Missense_Mutation | c.358G>T | p.Asp120Tyr | p.D120Y | P53567 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
CEBPG | SNV | Missense_Mutation | novel | c.115N>A | p.Pro39Thr | p.P39T | P53567 | protein_coding | deleterious(0) | benign(0.001) | TCGA-EY-A1GF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CEBPG | SNV | Missense_Mutation | novel | c.206G>A | p.Arg69Gln | p.R69Q | P53567 | protein_coding | deleterious(0) | probably_damaging(0.943) | TCGA-EY-A549-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CEBPG | SNV | Missense_Mutation | novel | c.278N>A | p.Arg93Lys | p.R93K | P53567 | protein_coding | tolerated(0.37) | benign(0.01) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
CEBPG | insertion | Frame_Shift_Ins | novel | c.402_403insGTAGAAA | p.Ser135ValfsTer5 | p.S135Vfs*5 | P53567 | protein_coding | TCGA-AP-A053-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |